Last reviewed · How we verify

NCT03469453: BIPWorry

Internet-delivered CBT for Adolescents With GAD

Completed NA Last updated 6 May 2019
What this trial tests

NA trial testing Internet-Delivered Cognitive Behavioral Therapy in Generalized Anxiety Disorder in 13 participants. Completed in 28 August 2018.

Timeline
28 November 2017
Primary endpoint
28 August 2018
28 August 2018

Quick facts

Lead sponsorKarolinska Institutet
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment13
Start date28 November 2017
Primary completion28 August 2018
Estimated completion28 August 2018
Sites1 location across Sweden

Drugs / interventions tested

Conditions studied

Sponsor

Karolinska Institutet

Who can join

Adults 13 to 17, any sex, with Generalized Anxiety Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This multiple baseline evaluation aims to test the feasibility and preliminary effectiveness of Internet-delivered cognitive behavioral therapy (ICBT) for adolescents with Generalized Anxiety Disorder (GAD).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Online cognitive behavior therapy for adolescents with excessive worry: a multiple baseline design feasibility study.
    Wahlund T, Jolstedt M, Andersson E, Vigerland S, et al · · 2020 · cited 7× · PMID 32190616 · DOI 10.21037/mhealth.2019.09.10

Verify or expand the search:

Other trials of Internet-Delivered Cognitive Behavioral Therapy

Trials testing the same drug.

Other recruiting trials for Generalized Anxiety Disorder

Currently open trials in the same condition.

Other Karolinska Institutet trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03469453.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing